Download PDF
Diabetes aktuell 2014; 12(5): 232-236
DOI: 10.1055/s-0034-1393719
Schwerpunkt
© Georg Thieme Verlag Stuttgart · New York

Peritonealdialyse bei diabetischer Nephropathie – Ein Überblick

Peritonealdialysis in diabetic ESRD-patients – an overview
Mark Dominik Alscher
1   Zentrum für Innere Medizin, Abteilung für Allgemeine Innere Medizin und Nephrologie, Robert-Bosch-Krankenhaus gGmbH, Stuttgart
› Author Affiliations
Further Information

Publication History

Publication Date:
12 September 2014 (online)

Also available at
    Permissions and Reprints

Der Typ-2-Diabetes nimmt weltweit zu und damit auch die diabetischen Nephropathien. In ca. 15 % kann ein Nierenersatz notwendig werden. Kommt eine primäre, präemptive Nierentransplantation nicht in Betracht, muss eine Dialyse eingeleitet werden. Neuere Leitlinien empfehlen die Peritonealdialyse (PD) als Dialyseverfahren der Wahl für Diabetiker. Dies ist begründbar durch ein besseres Überleben in den ersten Jahren der Behandlung, einen besseren Erhalt der Restnierenfunktion, und weitere Faktoren wie Lebensqualität, Mobilität etc., die aber nicht Gegenstand der Übersicht sind. Es ist erstaunlich, dass die Peritonealdialyse in Deutschland nur einen Anteil unter 5 % hat. Bei aufgeklärten Patienten und freier Verfahrenswahl beträgt der PD-Anteil 30–50 %. Dies sollte angestrebt werden.

The diabetes typ 2 has increasing numbers worldwide. In a percentage of 15 % this is leading to the urge of renal replacement therapy. Major goal is a preemptive kidney transplantation. However, if that is not feasible, dialysis is indicated. New german guidelines recommend the peritonealdialysis as the modality of choice for diabetic ESRD-patients. The arguments are better survival in the first years of treatment, better preservation of residual renal function, and other factors as live quality, mobility and more. The latter will not be discussed in the review. For some people it is astonishing that the numbers of PD in Germany are below 5 %. If patients have the chance for an informed consent, the numbers should be around 30–50 % and this should be the goal for the future.

Key words

Diabetes - dialysis - peritonealdialysis - mortality - glucose - advanced glycation endproducts - glucose degradation products
 

  • Literatur

  • 1 American Diabetes A. Standards of medical care in diabetes-2010. Diabetes Care 2010; 33 (Suppl. 01) 11-61
    Google Scholar
  • 2 Yang W, Lu J, Weng J et al. China National D, Metabolic Disorders Study G. Prevalence of diabetes among men and women in China. N Engl J Med 2010; 362: 1090-1101
    CrossrefPubMedGoogle Scholar
  • 3 Mokdad AH, Ford ES, Bowman BA et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003; 289: 76-79
    CrossrefGoogle Scholar
  • 4 Krolewski AS, Warram JH, Christlieb AR, Busick EJ, Kahn CR. The changing natural history of nephropathy in type I diabetes. Am J Med 1985; 78: 785-794
    CrossrefPubMedGoogle Scholar
  • 5 Krolewski M, Eggers PW, Warram JH. Magnitude of end-stage renal disease in IDDM: a 35 year follow-up study. Kidney Int 1996; 50: 2041-2046
    CrossrefGoogle Scholar
  • 6 Matsushima M, Tajima N, LaPorte RE et al. Markedly increased renal disease mortality and incidence of renal replacement therapy among IDDM patients in Japan in contrast to Allegheny County, Pennsylvania, USA. Diabetes Epidemiology Research International (DERI) U.S.-Japan Mortality Study Group. Diabetologia 1995; 38: 236-243
    CrossrefGoogle Scholar
  • 7 Bojestig M, Arnqvist HJ, Hermansson G, Karlberg BE, Ludvigsson J. Declining incidence of nephropathy in insulin-dependent diabetes mellitus. N Engl J Med 1994; 330: 15-18
    CrossrefGoogle Scholar
  • 8 Finne P, Reunanen A, Stenman S, Groop PH, Gronhagen-Riska C. Incidence of end-stage renal disease in patients with type 1 diabetes. JAMA 2005; 294: 1782-1787
    CrossrefGoogle Scholar
  • 9 Cowie CC, Rust KF, Ford ES et al. Full accounting of diabetes and pre-diabetes in the U.S. population in 1988–1994 and 2005–2006. Diabetes Care 2009; 32: 287-294
    CrossrefPubMedGoogle Scholar
  • 10 Adler AI, Stevens RJ, Manley SE et al. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney international 2003; 63: 225-232
    CrossrefGoogle Scholar
  • 11 U.S. Renal Data System UADR. Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, 2012. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD. 2012
    Google Scholar
  • 12 Kasiske BL, Snyder JJ, Matas AJ et al. Preemptive kidney transplantation: the advantage and the advantaged. J Am Soc Nephrol 2002; 13: 1358-1364
    CrossrefGoogle Scholar
  • 13 Chou CY, Liang CC, Kuo HL et al. Comparing risk of new onset diabetes mellitus in chronic kidney disease patients receiving peritoneal dialysis and hemodialysis using propensity score matching. PLoS One 2014; 9
    Google Scholar
  • 14 Quellhorst E. Insulin therapy during peritoneal dialysis: pros and cons of various forms of administration. J Am Soc Nephrol 2002; 13 (Suppl. 01) 92-96
    Google Scholar
  • 15 Rippe B, Davies S. Permeability of peritoneal and glomerular capillaries: what are the differences according to pore theory? Peritoneal dialysis international: journal of the International Society for Peritoneal Dialysis. 2011; 31: 249-258
    Google Scholar
  • 16 Braun N, Fritz P, Biegger D et al. Difference in the expression of hormone receptors and fibrotic markers in the human peritoneum-implications for therapeutic targets to prevent encapsulating peritoneal sclerosis. Perit Dial Int 2011; 31: 291-300
    CrossrefGoogle Scholar
  • 17 Frank RN. Diabetic retinopathy. N Engl J Med 2004; 350: 48-58
    CrossrefGoogle Scholar
  • 18 Williams JD, Craig KJ, von Ruhland C, Topley N, Williams GT. The natural course of peritoneal membrane biology during peritoneal dialysis. Kidney Int Suppl 2003; 88 (Suppl. 01) 43-49
    Google Scholar
  • 19 Mizumasa T, Hirakata H, Kuroki Y et al. Diabetes influences peritoneal morphology in uremic patients at the initiation of peritoneal dialysis. Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis. 2013; 33: 175-181
    Google Scholar
  • 20 Davies SJ. Longitudinal relationship between solute transport and ultrafiltration capacity in peritoneal dialysis patients. Kidney Int 2004; 66: 2437-2445
    CrossrefGoogle Scholar
  • 21 Himmele R, Jensen L, Fenn D et al. A New Neutral-pH Low-GDP Peritoneal Dialysis Fluid. Perit Dial Int 2012; 32: 444-452
    CrossrefGoogle Scholar
  • 22 Lin X, Lin A, Ni Z et al. Daily peritoneal ultrafiltration predicts patient and technique survival in anuric peritoneal dialysis patients. Nephrol Dial Transplant 2010; 25: 2322-2327
    CrossrefGoogle Scholar
  • 23 Han SH, Ahn SV, Yun JY, Tranaeus A, Han DS. Mortality and Technique Failure in Peritoneal Dialysis Patients Using Advanced Peritoneal Dialysis Solutions. Am J Kidney Dis 2009; 54: 711-720
    CrossrefGoogle Scholar
  • 24 Johnson DW, Brown FG, Clarke M et al. Effects of biocompatible versus standard fluid on peritoneal dialysis outcomes. J Am Soc Nephrol 2012; 23: 1097-1107
    CrossrefGoogle Scholar
  • 25 Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol 1996; 7: 198-207
    Google Scholar
  • 26 Moist LM, Port FK, Orzol SM et al. Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol 2000; 11: 556-564
    Google Scholar
  • 27 Jansen MA, Hart AA, Korevaar JC et al. Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int 2002; 62: 1046-1053
    CrossrefGoogle Scholar
  • 28 McDonald SP, Marshall MR, Johnson DW, Polkinghorne KR. Relationship between dialysis modality and mortality. J Am Soc Nephrol 2009; 20: 155-163
    CrossrefGoogle Scholar
  • 29 Weinhandl ED, Foley RN, Gilbertson DT et al. Propensity-matched mortality comparison of incident hemodialysis and peritoneal dialysis patients. J Am Soc Nephrol 2010; 21: 499-506
    CrossrefGoogle Scholar
  • 30 Yang X, Yi C, Liu X et al. Clinical outcome and risk factors for mortality in Chinese patients with diabetes on peritoneal dialysis: a 5-year clinical cohort study. Diabetes research and clinical practice 2013; 100: 354-361
    CrossrefGoogle Scholar
  • 31 Mehrotra R, Chiu YW, Kalantar-Zadeh K, Vonesh E. The outcomes of continuous ambulatory and automated peritoneal dialysis are similar. Kidney Int 2009; 76: 97-107
    CrossrefPubMedGoogle Scholar
  • 32 Mehrotra R, Chiu YW, Kalantar-Zadeh K, Bargman J, Vonesh E. Similar outcomes with hemodialysis and peritoneal dialysis in patients with end-stage renal disease. Arch Intern Med 2011; 171: 110-118
    Google Scholar
  • 33 Yeates K, Zhu N, Vonesh E et al. Hemodialysis and peritoneal dialysis are associated with similar outcomes for end-stage renal disease treatment in Canada. Nephrol Dial Transplant 2012; 27: 3568-3575
    CrossrefGoogle Scholar
  • 34 Lukowsky LR, Mehrotra R, Kheifets L et al. Comparing Mortality of Peritoneal and Hemodialysis Patients in the First 2 Years of Dialysis Therapy: A Marginal Structural Model Analysis. Clin J Am Soc Nephrol 2013; 8: 619-628
    CrossrefPubMedGoogle Scholar
  • 35 Nelson CB, Port FK, Wolfe RA, Guire KE. Comparison of continuous ambulatory peritoneal dialysis and hemodialysis patient survival with evaluation of trends during the 1980s. J Am Soc Nephrol 1992; 3: 1147-1155
    Google Scholar
  • 36 Vonesh EF, Snyder JJ, Foley RN, Collins AJ. The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis. Kidney Int 2004; 66: 2389-2401
    CrossrefGoogle Scholar
  • 37 Lukowsky LR, Mehrotra R, Kheifets L et al. Comparing mortality of peritoneal and hemodialysis patients in the first 2 years of dialysis therapy: a marginal structural model analysis. Clin J Am Soc Nephrol 2013; 8: 619-628
    CrossrefPubMedGoogle Scholar
  • 38 Cooper BA, Branley P, Bulfone L et al. A randomized, controlled trial of early versus late initiation of dialysis. N Engl J Med 2010; 363: 609-619
    CrossrefPubMedGoogle Scholar
  • 39 Goovaerts T, Jadoul M, Goffin E. Influence of a pre-dialysis education programme (PDEP) on the mode of renal replacement therapy. Nephrol Dial Transplant 2005; 20: 1842-1847
    CrossrefGoogle Scholar
  • 40 Lameire N, Van Biesen W. Epidemiology of peritoneal dialysis: a story of believers and nonbelievers. Nat Rev Nephrol 2010; 6: 75-82
    CrossrefGoogle Scholar